Stock in News: A Review Of The Facebook (NASDAQ FB) Earnings

Facebook Inc (NASDAQ FB) released its highly-anticipated Q3 report on Tuesday, October 28th. In the past 10 years since Facebook’s inception, the website has gone from a mere vision in a Harvard dorm room to a household name and cornerstone of social media. In the Q3 report, Facebook Inc (NASDAQ FB) reported $0.43 earnings per share on a Non-GAAP basis, beating the analyst consensus of … Continue reading Stock in News: A Review Of The Facebook (NASDAQ FB) Earnings

Montreal Canadiens Live Stream NHL Game Video Ice Hockey Goals Replay

Join the Rest in Enjoying Vancouver Canucks vs Montreal Canadiens Live Stream and NHL Video Highlights

Tonight’s Vancouver Canucks vs Montreal Canadiens live stream can be watched from 10:00PM ET by following the links we have provided below. Canadiens are coming into Vancouver Canucks vs Montreal Canadiens game with a three game winning streak against Vancouver Canucks. Canucks lost last Friday, but have managed to register two home wins after that. They have a 6-3-0 record while the Montreal Canadiens are … Continue reading Join the Rest in Enjoying Vancouver Canucks vs Montreal Canadiens Live Stream and NHL Video Highlights

Bringing You Cleveland Cavaliers vs New York Knicks Live Stream + NBA Video Highlights

The Cleveland Cavaliers vs New York Knicks game is going down today Thursday October 30, 2014, at the Quicken Loans Arena, Cleveland, Ohio, from 8:00PM ET. Cleveland Cavaliers did very well in the pre-season and will be looking to put up a good performance against the average New York Knicks. With LeBron James in for the Cavaliers, the team must be charged to register their … Continue reading Bringing You Cleveland Cavaliers vs New York Knicks Live Stream + NBA Video Highlights

Regeneron and Partner Announced Positive First Trial Results of Odyssey

Regeneron and its partner Sanofi announced positive results in the first trial of their extensive Phase III ODYSSEY program (12 trials in total) for alirocumab (REGN-727), which targets PCSK9 to lower LDL (or “bad”) cholesterol. Alirocumab showed a 47.2% reduction in LDL levels from baseline over 24 weeks in patients with primary hypercholesterolemia and moderate cardiovascular risk, compared to 15.6% in patients treated with Zetia … Continue reading Regeneron and Partner Announced Positive First Trial Results of Odyssey